↓ Skip to main content

Refractory Sarcoidosis: A Review

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Refractory Sarcoidosis: A Review
Published in
Therapeutics and Clinical Risk Management, April 2020
DOI 10.2147/tcrm.s192922
Pubmed ID
Authors

Thomas El Jammal, Yvan Jamilloux, Mathieu Gerfaud-Valentin, Dominique Valeyre, Pascal Sève

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 78 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 14%
Student > Bachelor 10 13%
Researcher 6 8%
Student > Ph. D. Student 6 8%
Student > Doctoral Student 5 6%
Other 15 19%
Unknown 25 32%
Readers by discipline Count As %
Medicine and Dentistry 26 33%
Nursing and Health Professions 4 5%
Neuroscience 3 4%
Biochemistry, Genetics and Molecular Biology 2 3%
Business, Management and Accounting 2 3%
Other 12 15%
Unknown 29 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2020.
All research outputs
#15,163,176
of 25,386,384 outputs
Outputs from Therapeutics and Clinical Risk Management
#667
of 1,322 outputs
Outputs of similar age
#193,186
of 374,655 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#4
of 19 outputs
Altmetric has tracked 25,386,384 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,322 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 374,655 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.